Press Releases

The Commission on Cancer (CoC), a quality program of the American College of Surgeons, has fully reaccredited Roswell Park Comprehensive Cancer Center for three years. The Commission on Cancer gives recognition to cancer centers that provide multidisciplinary, patient-centered cancer care. Roswell Park is one of the longest-standing CoC programs, having maintained accreditation from the organization continuously since 1931.

A program designed to help African Americans make informed decisions about prostate cancer early detection and treatment will expand in Erie County thanks to a New York State Department of Health (DOH) grant to Adam Sumlin, PhD, MBA, Assistant Professor of Oncology at Roswell Park Comprehensive Cancer Center. The grant — one of only four awarded in the state — provides $650,000 over the next five years through the DOH program Peer Education, Outreach & Shared Decision-Making for Persons at High Risk of Prostate Cancer.

Roswell Park has transformed a 150-year-old residence at 907 Michigan Ave., blending history and vision into a welcoming new home for its community outreach: the Roswell Park Community Outreach & Engagement Center. Roswell Park team members, patients, advocates and community leaders gathered for a grand opening of the renovated and expanded space.

Gov. Kathy Hochul announced that New York's first cell and gene therapy hub will be housed at Roswell Park. The $98 million center will help to support the research and development of life-saving therapies at Roswell, significantly grow its well-established research capabilities, and establish Roswell as one of the premier cell therapy discovery and production institutions in the nation.

A promising cancer innovation developed at Roswell Park Comprehensive Cancer Center has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA). The designation awarded to MimiVax Inc. provides more extensive and accelerated access to FDA resources for the company’s development of the novel cancer immunotherapy SurVaxM, which is now in late-stage trials around the country.

While most patients treated with radiation therapy for cancers of the head and neck develop oral mucositis, there is no standard approach for monitoring those patients for this often-debilitating side effect of cancer treatment or for measuring its severity. In new work published today by JAMA Network Open, a research team at Roswell Park Comprehensive Cancer Center shows that more patients than previously thought experience mucositis and can benefit from earlier diagnosis and intervention to address its effects.

A program launched at Roswell Park Comprehensive Cancer Center three years ago to advance health equity and access by strengthening connections between cancer researchers and Indigenous communities has grown into a broad-based team of Indigenous experts with an expanded scope and purpose. The cancer center’s new Department of Indigenous Cancer Health reflects the significant growth of an initiative led since its inception by health disparities expert Rodney Haring, PhD, MSW, an enrolled member of the Seneca Nation of Indians, Beaver Clan.

Opening the doors to specialized cancer and dermatology services to patients in Niagara County and beyond, Roswell Park Care Network leaders announce their newest practice in Lockport.